Search

Search Results

• Efficacy and Safety of Various Treatment Regimens for Primary CNS Lymphoma: Results of a Retrospective Study Based on the Data from Nine Saint Petersburg Medical Institutions

  Vladislav Vitalevich Markelov, Iu.S. Osipov, Yu.A. Alekseeva, S.V. Voloshin, N.A. Khasanova, S.A. Volchenkov, E.A. Ukrainchenko, E.S. Pavlyuchenko, A.Yu. Kuvshinov, Ju.N. Vinogradova, A.N. Gavrilenko, O.S. Uspenskaya, M.A. Ulyanova, V.G. Potapenko, I.A. Samorodova, V.V. Ryabchikova, I.S. Zyuzgin, A.M. Chekalov, M.V. Krivitskaya, Ya.B. Skiba, M.O. Popova, E.V. Kondakova, L.V. Stelmakh, L.V. Fedorova, K.V. Lepik, A.A. Gusak, V.V. Baykov, N.V. Medvedeva, G.N. Salogub, N.B. Mikhailova, A.D. Kulagin

  253-263

  01.07.2026

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma: A Literature Review and Our Own Experience

  Ulyana Gordeevna Koshkina, A.A. Semenova, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.I. Cherencova, S.F. Ramazanova, N.O. Zemlyakov, I.Z. Zavodnova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, G.S. Tumyan

  59-69

  01.01.2026

• Successful Treatment of Refractory Immune Thrombotic Thrombocytopenic Purpura with Daratumumab

  E.E. Klebanova, Gennadii Martinovich Galstyan, S.Yu. Mamleeva, D.K. Bessmertnyy, Z.T. Fidarova, E.N. Parovichnikova

  270-276

  01.07.2025

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• Primary Mediastinal (Thymic) Large B-Cell Lymphoma and Classical Hodgkin Lymphoma: A Rare Case of Synchronous Lymphoid Tumors

  Leonid Aleksandrovich Kramynin, S.S. Elkhova, A.G. Kolgotina, L.V. Filatova, I.S. Zyuzgin, A.L. Muravtseva, R.V. Grozov

  209-217

  01.07.2025

• Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center

  Ulyana Gordeevna Koshkina, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, N.A. Kupryshina, E.A. Osmanov

  121-133

  01.04.2025

• Novel Coronavirus Infection COVID-19 and the Status of Humoral Immune Response in Patients with Hematologic Malignancies

  Elena Valentinovna Ignateva, O.A. Rukavitsyn, S.P. Kazakov

  415-421

  01.10.2024

• Bone Marrow Lymphocyte Subpopulation in Chronic Lymphocytic Leukemia Patients with Different Responses to Chemotherapy

  Olesya Nikolaevna Selyutina, E.Yu. Zlatnik, N.K. Guskova, I.A. Novikova, I.B. Lysenko, A.B. Sagakyants, T.F. Pushkareva, L.Yu. Vladimirova

  376-383

  01.10.2024

• Sarcoid-like Pulmonary Lesion in a Female Patient with Multiple Myeloma and Systemic AL Amyloidosis Treated with Daratumumab: A Case of Spontaneous Regression of Lung Tissue Changes upon Drug Withdrawal

  Irina Germanovna Rekhtina, V.A. Khyshova, A.M. Kovrigina, M.A. Silaev, L.P. Mendeleeva

  370-375

  01.10.2024

• Therapy Optimization in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Efficacy and Safety of the R-SD-EPOCH ± HDMTX Program Under Single-Center Non-Randomized Prospective Clinical Trial (Preliminary Results)

  Marat Albertovich Mingalimov

  173-179

  01.04.2024

• Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

  Ekaterina Sergeevna Nesterova, E.E. Zvonkov, A.M. Kovrigina, T.N. Obukhova, B.V. Biderman, A.B. Sudarikov, Ya.K. Mangasarova, A.U. Magomedova, A.K. Smolyaninova, S.M. Kulikov, E.N. Parovichnikova

  361-369

  28.09.2023

• Experience with the Use of B-RAF Inhibitor Vemurafenib in the Treatment of Hairy Cell Leukemia

  L.S. Al-Radi, Svetlana Yurevna Smirnova, T.N. Moiseeva, I.S. Piskunova, L.V. Plastinina, D.V. Novikova, E.G. Gemdzhian, G.M. Galstyan

  349-355

  01.10.2022

• Efficacy and Safety of Pola-BR Combination in Relapsed/Refractory Aggressive В-Cell Non-Hodgkin’s Lymphomas: A Russian Multi-Center Study

  Olesya Gennadevna Smykova, A.A. Semenova, Yu.B. Chernykh, T.A. Mitina, A.V. Kildyushevskii, S.K. Kravchenko, A.E. Misyurina, A.U. Magomedova, E.A. Baryakh, S.V. Samarina, N.P. Volkov, V.V. Markelov, P.V. Kotselyabina, L.V. Fedorova, K.V. Lepik, E.V. Kondakova, L.V. Stelmakh, V.V. Baykov, N.B. Mikhailova, I.S. Moiseev, G.S. Tumyan, E.A. Osmanov, A.D. Kulagin

  232-239

  01.07.2022

• Treatment of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

  Aleksander Sergeevich Luchinin

  130-139

  01.04.2022

• Mantle Cell Lymphoma: History, Current Principles of Diagnosis, and Treatment (Literature Review)

  Gayane Sepugovna Tumyan

  366-381

  01.10.2020

• A Case of M-Paraprotein-Associated Polyneuropathy with Stable Response to Rituximab Therapy

  Vsevolod Gennad’evich Potapenko, V.N. Kiselev

  434-437

  01.10.2019

• Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina

  154-164

  01.04.2019

• Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia

  Yuliya Vladimirovna Mirolyubova, E.A. Stadnik, V.V. Strugov, T.O. Andreeva, T.S. Nikulina, Yu.V. Virts, P.A. Butylin, A.G. Rumyantsev, A.Yu. Zaritskey

  167-174

  01.04.2018

• Effect of Patients’ Endocrine Status on Effectiveness of Treatment with Rituximab: State of the Art

  Yuliya Valer’evna Komoza, V.A. Komoza, S.V. Chernavskii, O.A. Rukavitsyn

  187-190

  01.04.2017

• Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report

  Ol’ga Mikhailovna Volodina, N.A. Kupryshina, N.A. Falaleeva, V.A. Doronin, A.V. Mozhenkova, M.A. Frenkel’, E.N. Sorokin, N.V. Kokosadze, N.N. Tupitsyn, G.S. Tumyan, E.A. Osmanov

  176-181

  01.04.2017

• Molecular Genetic Abnormalities in the Pathogenesis of Hematologic Malignancies and Corresponding Changes in Cell Signaling Systems

  L.R. Tilova, A.V. Savinkova, E.M. Zhidkova, O.I. Borisova, T.I. Fetisov, K.A. Kuzin, O.A. Vlasova, A.S. Antipova, O.Yu. Baranova, K.I. Kirsanov, G.A. Belitskii, M.G. Yakubovskaya, Ekaterina Andreevna Lesovaya

  235-249

  01.04.2017

• Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia

  Vladimir Vladimirovich Strugov, E.A. Stadnik, A.M. Rumyantsev, T.O. Andreeva, Yu.V. Virts, Yu.V. Mirolyubova, P.A. Butylin, A.Yu. Zaritskey

  141-149

  01.04.2017

• Stevens-Johnson Syndrome after Treatment of Female Patient with Small Lymphocytic B-Cell Lymphoma, Autoimmune Hemolytic Anemia and Antiphospholipid Antibody Syndrome with Rituximab

  A.L. Melikyan, Irina Nikolaevna Subortseva, A.M. Kovrigina, T.I. Kolosheinova, E.K. Egorova, E.I. Pustovaya

  120-127

  01.01.2017

• Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experience

  Timur Teimurazovich Valiev, A.V. Popa, A.S. Levashov, E.S. Belyaeva, N.S. Kulichkina, B.V. Kurdyukov, R.S. Ravshanova, G.L. Mentkevich

  420-437

  01.10.2016

• Monoclonal Antibodies: from Development to Clinical Application

  Yurii Ivanovich Budchanov

  237-244

  01.07.2016

• Secondary Hemophagocytic Syndrome in the Adult Patients. Literature Review and Authors’ Experience

  Vsevolod Gennad’evich Potapenko, N.A. Potikhonova, V.V. Baikov, M.B. Belogurova, I.A. Lisukov, A.V. Klimovich, S.V. Lapin, M.O. Ivanova, V.M. Kravtsova, E.I. Podol’tseva, N.V. Medvedeva, B.V. Afanas’ev

  169-184

  01.04.2015

• High-Dose Chemotherapy for Grade 3B Relapsed Follicular Lymphoma with Deletions of Loci of BCL6 (3q27) and TP53 (17p13) Genes: Case Report and Literature Review

  E.E. Zvonkov, Nelli Georgievna Gabeeva, M.V. Firsova, E.V. Moiseeva, V.V. Troitskaya, L.A. Kuz’mina, T.N. Obukhova, A.M. Kovrigina, E.N. Parovichnikova, V.G. Savchenko

  36–43

  01.01.2015

• Rare Disease — Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma: Literature Review and Own Data

  E.A. Demina, G.S. Tumyan, A.A. Chekan, M.Yu. Kichigina, A.S. Antipova, N.A. Probatova, A.I. Pavlovskaya, N.V. Kokosadze, A.M. Kovrigina, O.P. Trofimova, E.A. Osmanov

  522-532

  01.10.2014

• Optimization of diagnosis and treatment of Burkitt’s lymphoma in children, adolescents, and young adults

  T.T. Valiyev, Ye.A. Baryakh, P.A. Zeynalova, A.M. Kovrigina, S.K. Kravchenko, T.N. Obukhova, N.А. Falaleyeva, A.I. Senderovich, I.N. Serebryakova, I.V. Kaminskaya, A.S. Levashov, G.L. Mentkevich

  175-183

  01.04.2014

• Evolution of concepts for diagnosis and treatment of Burkitt’s lymphoma

  T.T. Valiev, E.A. Baryakh

  46-56

  01.01.2014

• Rituximab (MabThera) for subcutaneous administration, new opportunities well-studied drug

  G.S. Tumyan

  67-70

  01.01.2014

• Pulmonary MALT-lymphoma: case report and literature review

  A.K. Morozova, N.G. Gabeeva, E.E. Zvonkov

  282-288

  01.07.2013

• Mantle cell lymphoma: program therapy for untreated patients under 65 years

  V.I. Vorobyev, S.K. Kravchenko, E.G. Gemdjian, Yu.Yu. Lorie, A.U. Magomedova, A.L. Melikyan, J.K. Mangasarova, D.S. Mar’yin, E.I. Dubrovin, T.N. Obukhova, S.A. Makhinya, V.A. Zherebtsova, M.A. Vernyuk, N.G. Tyurina, V.G. Savchenko

  274-281

  01.07.2013

• Use of rituximab for treatment of HIV-infected patients with hematological disorders

  A.V. Pivnik

  85-91

  01.01.2013